4.01

0.25% 0.010

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Overview News Price History Financials Discussions Forecast

Shuttle Pharmaceuticals Holdings Inc stock is traded at $4.01, with a volume of 20,180. It is up +0.25% in the last 24 hours and up +16.57% over the past month. Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Previous Close:

$4.00

Open:

$3.87

24h Volume:

20,180

Relative Volume:

0.01

Market Cap:

$2.35M

Revenue:

Net Income/Loss:

$-10.82M

P/E Ratio:

-0.6614

EPS:

-6.0625

Net Cash Flow:

$-9.42M

1W Performance:

+24.92%

1M Performance:

+16.57%

6M Performance:

+347.39%

1Y Performance:

-3.26%

1-Day Range:

$3.87

$4.223

1-Week Range:

$3.21

$4.223

52-Week Range:

$0.3832

$6.15

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile

Name

Shuttle Pharmaceuticals Holdings Inc

Sector

Healthcare (1067)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

(240) 403-4212

Address

401 PROFESSIONAL DRIVE, GAITHERSBURG

Employee

Twitter

Next Earnings Date

2026-11-12

Latest SEC Filings

SHPH's Discussions on Twitter

Compare SHPH vs TAK, TEVA, HLN, ZTS, VTRS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SHPH Shuttle Pharmaceuticals Holdings Inc	4.01	2.35M	0	-10.82M	-9.42M	-6.0625
TAK Takeda Pharmaceutical Co Adr	18.86	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.19	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.26	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	71.05	29.36B	9.51B	2.64B	2.14B	6.0361
VTRS Viatris Inc	17.83	20.48B	14.57B	-296.50M	1.64B	-0.259

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News

Sep 25, 2026

Shuttle Pharmaceuticals (SHPH) Stock Analysis Report | Financials & Insights - es.benzinga.com

Sep 25, 2026

Sep 24, 2026

Shuttle Pharmaceuticals Q2 Results: Loss per share narrows 90.6% YoY - scanx.trade

Sep 24, 2026

Shuttle Pharmaceuticals Holds $13.68 Million United Dogecoin Investment - Minichart

Sep 24, 2026

Shuttle Pharmaceuticals Corrects Pre-Funded Warrant Count to 9,741,751 From 16,932,508 - Minichart

Sep 24, 2026

Shuttle Pharmaceuticals Revises Pre-Funded Warrant Figures in SEC Filing - Kalkine Media

Sep 24, 2026

Form 8K Shuttle Pharmaceuticals Inc For: 24 September By Investing.com - Investing.com India

Sep 24, 2026

Shuttle Pharmaceuticals Holdings, Inc. Q2 2026: Revenue $0 Net loss $(3.15M), EPS $(3.10) — 10-Q Summary - TradingView

Sep 24, 2026

Shuttle Pharmaceuticals : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com

Sep 24, 2026

Shuttle Pharmaceuticals corrects warrant count to 9.74M - Stock Titan

Sep 24, 2026

Sep 20, 2026

Shuttle Pharmaceuticals (SHPH) Slides 5.03% to $3.21, Drifting Toward Key SupportUp Down Ratio - siam.in

Sep 20, 2026

Sep 16, 2026

Shuttle Pharmaceuticals Restructures Capital Through New Securities - TipRanks

Sep 16, 2026

Sep 15, 2026

Shuttle Pharmaceuticals (SHPH) details new stock and warrant issuances - Stock Titan

Sep 15, 2026

Sep 12, 2026

5 Biotech Stocks with Highly Anticipated Pending Results - stocktwits.com

Sep 12, 2026

SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today - Stocktwits

Sep 12, 2026

Sep 11, 2026

Form 8K Shuttle Pharmaceuticals Inc For: 11 September By Investing.com - Investing.com South Africa

Sep 11, 2026

Shuttle Pharmaceuticals shareholders approve merger proposals and company name change - Investing.com

Sep 11, 2026

Shuttle Pharmaceuticals Shareholders Approve Merger and Renaming - TipRanks

Sep 11, 2026

Shuttle Pharmaceuticals Holdings, Inc. has Changed its Name to United Compute Inc - marketscreener.com

Sep 11, 2026

Shuttle Pharma (NASDAQ: SHPH) investors back name change and multi-million-share expansion - Stock Titan

Sep 11, 2026

Sep 02, 2026

Shuttle Pharmaceuticals Reschedules Upcoming Special Stockholder Meeting - TipRanks

Sep 02, 2026

Shuttle Pharma (SHPH) moves special meeting to Sept. 9 - Stock Titan

Sep 02, 2026

Sep 01, 2026

Dogecoin mining target slashed in Shuttle Pharma (NASDAQ: SHPH) merger deal - Stock Titan

Sep 01, 2026

Aug 29, 2026

Shuttle Pharmaceuticals Receives Nasdaq Noncompliance Notice Over 10-Q - The Globe and Mail

Aug 29, 2026

Aug 28, 2026

Shuttle Pharmaceuticals Faces Nasdaq Delisting Risk Over Delayed 10-Q Filing - Minichart

Aug 28, 2026

Shuttle Pharmaceuticals fails to meet Nasdaq filing requirements By Investing.com - Investing.com Canada

Aug 28, 2026

Shuttle Pharmaceuticals Received Notice of Noncompliance - TradingView

Aug 28, 2026

Shuttle Pharmaceuticals Holdings, Inc. Announces Receipt of NASDAQ Noncompliance Letter - TMX Newsfile

Aug 28, 2026

Aug 18, 2026

This Tiny Biotech Wants To Mine Dogecoin – And Traders Are Loving It - Stocktwits

Aug 18, 2026

Aug 17, 2026

Shuttle Pharmaceuticals Delays Quarterly SEC Filing - TipRanks

Aug 17, 2026

Shuttle Pharmaceuticals Amends Merger Filing, Reclassifies UDC Transaction as Non-Business - Minichart

Aug 17, 2026

Shuttle Pharma (SHPH) slashes R&D 95% as Dogecoin legal bills climb - Stock Titan

Aug 17, 2026

Shuttle Pharma (NASDAQ: SHPH) rethinks Dogecoin merger accounting - Stock Titan

Aug 17, 2026

Shuttle Pharmaceuticals (SHPH) Holds Near $4.08 as Momentum Stalls at Key ResistanceIntraday Profile - vinanet.vn

Aug 17, 2026

Aug 16, 2026